| 22-May-13 06:30AM | InPlay: OncoGenex Pharma announces multiple 'trials in progress' presentations at the 2013 ASCO annual meeting Briefing.com |
| 06:30AM | OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting PR Newswire |
| 06:30AM | OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting CNW Group |
| 10-May-13 01:04PM | ONCOGENEX PHARMACEUTICALS, INC. Financials EDGAR Online Financials |
| 06-May-13 02:45PM | OncoGenex Loss Lower than Expected Zacks |
| 03-May-13 12:04PM | OncoGenex Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha +7.35% |
| 02-May-13 04:01PM | OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013 CNW Group |
| 04:00PM | OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013 PR Newswire |
| 09:10AM | ONCOGENEX PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen EDGAR Online |
| 07:07AM | Q1 2013 Oncogenex Pharmaceuticals, Inc. Earnings Release - After Market Close CCBN |
| 01-May-13 12:47PM | OncoGenex Pharmaceuticals Becomes Oversold (OGXI) at TheStreet -7.31% |
| 06:30AM | OncoGenex Announces Plans for the Initiation of the Rainier Clinical Trial Evaluating OGX-427 in Combination with ABRAXANE® plus Gemcitabine in Patients with Metastatic Pancreatic Cancer PR Newswire |
| 06:30AM | OncoGenex Announces Plans for the Initiation of the Rainier Clinical Trial Evaluating OGX-427 in Combination with ABRAXANE® plus Gemcitabine in Patients with Metastatic Pancreatic Cancer CNW Group |
| 30-Apr-13 08:22AM | OncoGenex initiates clincal trial of OGX-427 at theflyonthewall.com |
| 08:05AM | InPlay: OncoGenex Pharma announces that the Borealis-2 clinical trial of OGX-427 in previously treated metastatic bladder cancer is now open for enrollment Briefing.com |
| 08:01AM | OncoGenex Announces that the Borealis-2 Clinical Trial of OGX-427 in Previously Treated Metastatic Bladder Cancer is now Open for Enrollment CNW Group |
| 08:00AM | OncoGenex Announces that the Borealis-2 Clinical Trial of OGX-427 in Previously Treated Metastatic Bladder Cancer is now Open for Enrollment PR Newswire |
| 25-Apr-13 04:01PM | OncoGenex to Webcast Discussion of Clinical Development Program and First Quarter 2013 Financial Results on May 2, 2013 PR Newswire |
| 04:01PM | OncoGenex to Webcast Discussion of Clinical Development Program and First Quarter 2013 Financial Results on May 2, 2013 CNW Group |
| 23-Apr-13 04:01PM | OncoGenex Pharmaceuticals to Present at Upcoming Investor Conference PR Newswire |
| 04:01PM | OncoGenex Pharmaceuticals to Present at Upcoming Investor Conference CNW Group |
| 12-Apr-13 04:20PM | OncoGenex' OGX-427 Progresses Zacks |
| 01:45PM | OncoGenex: A Cancer Biotech Worth Betting On at Seeking Alpha |
| 11-Apr-13 08:01AM | OncoGenex Announces Plans for the Initiation of the Spruce Clinical Trial Evaluating OGX-427 in Combination with Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer CNW Group +5.00% |
| 08:00AM | OncoGenex Announces Plans for the Initiation of the Spruce Clinical Trial Evaluating OGX-427 in Combination with Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer PR Newswire |
| 28-Mar-13 04:01PM | OncoGenex Pharmaceuticals to Present at Upcoming Investor Conference PR Newswire |
| 04:01PM | OncoGenex Pharmaceuticals to Present at Upcoming Investor Conference CNW Group |
| 26-Mar-13 05:51PM | OncoGenex's Second Cancer Drug Gaining Investor Attention at Seeking Alpha |
| 13-Mar-13 01:04PM | ONCOGENEX PHARMACEUTICALS, INC. Financials EDGAR Online Financials |
| 07:58AM | OncoGenex: SYNERGY Trial Is The Major Catalyst In Sight at Seeking Alpha |
| 11-Mar-13 03:15PM | OncoGenex Loss Lower than Expected Zacks |
| 09-Mar-13 08:05PM | New Star Analyst Rankings for OncoGenex Pharmaceuticals Inc. StarMine |
| 08-Mar-13 08:02PM | New Star Analyst Rankings for OncoGenex Pharmaceuticals Inc. StarMine |
| 07-Mar-13 07:01PM | OncoGenex Pharmaceuticals Management Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha |
| 04:13PM | ONCOGENEX PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen EDGAR Online |
| 04:01PM | OncoGenex Pharmaceuticals, Inc. Provides Update on Clinical Development Program and Reports Financial Results for Fourth Quarter and Year End 2012 CNW Group |
| 04:00PM | OncoGenex Pharmaceuticals, Inc. Provides Update on Clinical Development Program and Reports Financial Results for Fourth Quarter and Year End 2012 PR Newswire |
| 07:07AM | Q4 2012 Oncogenex Pharmaceuticals, Inc. Earnings Release - After Market Close CCBN |
| 28-Feb-13 04:01PM | OncoGenex to Webcast Update on Clinical Development Program and Discussion of Fourth Quarter and Full Year 2012 Financial Results on Thursday, March 7, 2013 PR Newswire |
| 04:01PM | OncoGenex to Webcast Update on Clinical Development Program and Discussion of Fourth Quarter and Full Year 2012 Financial Results on Thursday, March 7, 2013 CNW Group |
| 14-Feb-13 04:18PM | OncoGenex' Candidate Progresses Zacks |
| 13-Feb-13 02:33PM | 4 Healthcare Stock Stories for Mid-Week Wellness at Wall St. Cheat Sheet |
| 12-Feb-13 08:12AM | OncoGenex announces plans for initiation of Borealis-2 clinical trial theflyonthewall.com |
| 08:02AM | InPlay: OncoGenex Pharma plans for the initiation of the Borealis-2 clinical trial evaluating OGX-427 in combination with second-line therapy for bladder cancer Briefing.com |
| 08:01AM | OncoGenex Announces Plans for the Initiation of the Borealis-2 Clinical Trial Evaluating OGX-427 in Combination with Second-Line Therapy for Bladder Cancer CNW Group |
| 08:00AM | OncoGenex Announces Plans for the Initiation of the Borealis-2 Clinical Trial Evaluating OGX-427 in Combination with Second-Line Therapy for Bladder Cancer PR Newswire |
| 05-Feb-13 04:01PM | OncoGenex Pharmaceuticals to Present at Upcoming Investor Conferences PR Newswire |
| 04:01PM | OncoGenex Pharmaceuticals to Present at Upcoming Investor Conferences CNW Group |
| 04-Feb-13 05:29PM | ONCOGENEX PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements a EDGAR Online |
| 14-Jan-13 06:21AM | The Zacks Analyst Blog Highlights: Isis Pharmaceuticals, Inc., Sanofi, GlaxoSmithKline, OncoGenex and Teva Pharmaceuticals Zacks |
| 02-Jan-13 06:02PM | Nasdaq stocks posting largest percentage increases AP |
| 31-Dec-12 06:04PM | Nasdaq stocks posting largest percentage increases AP +10.90% |
| 19-Dec-12 09:31AM | InPlay: OncoGenex Pharma announces initiation of randomized Phase 2 'PACIFIC' study of OGX-427 in combination with Zytiga in men with metastatic castrate-resistant prostate cancer Briefing.com |
| 09:30AM | OncoGenex Announces Initiation of Randomized Phase 2 "PACIFIC" Study of OGX-427 in combination with Zytiga® in Men with Metastatic Castrate-Resistant Prostate Cancer PR Newswire |
| 29-Nov-12 11:53AM | Prostate Cancer Market Takes Shape - Part 2: Treatments In Clinical Development at Seeking Alpha |
| 18-Nov-12 02:51PM | 2 Biopharmaceutical Stocks with Strong Net Cash at Motley Fool |
| 15-Nov-12 01:04PM | ONCOGENEX PHARMACEUTICALS, INC. Financials EDGAR Online Financials |
| 10-Nov-12 09:29AM | New Star Analyst Rankings for OncoGenex Pharmaceuticals Inc. StarMine |
| 09-Nov-12 09:32AM | New Star Analyst Rankings for OncoGenex Pharmaceuticals Inc. StarMine |
| 06:00AM | OncoGenex Pharmaceuticals to Present at Upcoming Investor Conference PR Newswire |
| 06:00AM | OncoGenex Pharmaceuticals to Present at Upcoming Investor Conference CNW Group |
| 08-Nov-12 10:00PM | OncoGenex Pharmaceuticals Management Discusses Q3 2012 Results - Earnings Call Transcript at Seeking Alpha |
| 04:13PM | ONCOGENEX PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen EDGAR Online |
| 04:09PM | OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Update and Reports Financial Results for Third Quarter 2012 CNW Group |
| 04:00PM | OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Update and Reports Financial Results for Third Quarter 2012 PR Newswire |
| 07:07AM | Q3 2012 Oncogenex Pharmaceuticals, Inc. Earnings Release - Time Not Supplied CCBN |
| 06-Nov-12 09:01AM | OncoGenex Announces Completion Of Patient Enrollment In Custirsen Phase 3 "SYNERGY" Study CNW Group |
| 09:00AM | OncoGenex Announces Completion Of Patient Enrollment In Custirsen Phase 3 "SYNERGY" Study PR Newswire |
| 30-Oct-12 04:00PM | OncoGenex to Webcast Discussion of Third Quarter 2012 Financial Results on Thursday, November 8, 2012 PR Newswire |
| 04:00PM | OncoGenex to Webcast Discussion of Third Quarter 2012 Financial Results on Thursday, November 8, 2012 CNW Group |
| 27-Sep-12 04:31PM | InPlay: OncoGenex Pharma announces initiation of a Phase 3 trial for curisten in advanced non-small cell lung cancer Briefing.com |
| 04:31PM | OncoGenex Announces Initiation Of A Phase 3 Trial For Custirsen In Advanced Non-Small Cell Lung Cancer CNW Group |
| 04:30PM | OncoGenex Announces Initiation Of A Phase 3 Trial For Custirsen In Advanced Non-Small Cell Lung Cancer PR Newswire |
| 13-Sep-12 04:57PM | Trius And OncoGenex Pharmaceuticals: On Their Game at Seeking Alpha |
| 28-Aug-12 04:01PM | OncoGenex Pharmaceuticals to Present at Two Upcoming Investor Conferences PR Newswire |
| 04:01PM | OncoGenex Pharmaceuticals to Present at Two Upcoming Investor Conferences CNW Group |
| 23-Aug-12 03:00AM | 3 Healthcare Stocks With Strong Buy Analyst Ratings And Minimal Debt at Seeking Alpha |
| 19-Aug-12 05:44AM | 5 Pharmaceutical Companies With Insider Buying During August 14-16 at Seeking Alpha |
| 09-Aug-12 01:04PM | ONCOGENEX PHARMACEUTICALS, INC. Financials EDGAR Online Financials |
| 07-Aug-12 09:31AM | InPlay: OncoGenex Pharma announces initiation of the Phase 3 'AFFINITY' trial for patients with advanced prostate cancer Briefing.com |
| 09:30AM | OncoGenex Announces Initiation of the Phase 3 "AFFINITY" Trial for Patients with Advanced Prostate Cancer PR Newswire |
| 09:30AM | OncoGenex Announces Initiation of the Phase 3 "AFFINITY" Trial for Patients with Advanced Prostate Cancer CNW Group |
| 03-Aug-12 10:58AM | New Star Analyst Rankings for OncoGenex Pharmaceuticals Inc. StarMine +6.52% |
| 02-Aug-12 04:12PM | ONCOGENEX PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen EDGAR Online |
| 04:02PM | OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427 CNW Group |
| 04:00PM | OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427 PR Newswire |
| 07:07AM | Q2 2012 Oncogenex Pharmaceuticals, Inc. Earnings Release - After Market Close CCBN |
| 25-Jul-12 04:01PM | OncoGenex to Webcast Discussion of Second Quarter 2012 Financial Results on Thursday, August 2, 2012 PR Newswire |
| 04:01PM | OncoGenex to Webcast Discussion of Second Quarter 2012 Financial Results on Thursday, August 2, 2012 CNW Group |
| 10-Jul-12 09:10AM | InPlay: OncoGenex Pharma announces clinical development plans for Custirsen in Non-Small Cell Lung Cancer; phase 3 trial initiated later this year Briefing.com |
| 09:02AM | OncoGenex Announces Clinical Development Plans for Custirsen in Non-Small Cell Lung Cancer CNW Group |
| 09:00AM | OncoGenex Announces Clinical Development Plans for Custirsen in Non-Small Cell Lung Cancer PR Newswire |
| 26-Jun-12 10:05AM | 3 Pharmaceutical Companies Seeing Insider Buys In Last 30 Days at Seeking Alpha |
| 18-Jun-12 02:47PM | UNVEILED: New Equity Analyst Coverage Shared With Public Investors at Wall St. Cheat Sheet |
| 09:20AM | New Stock Coverage: Unearthing Treasures in eBay's Attic at Minyanville |
| 12:48AM | Coverage initiated on OncoGenex Pharma by Needham Briefing.com |
| 04-Jun-12 01:31PM | Playing OncoGenex's ASCO Data at Seeking Alpha |
| 08:02AM | InPlay: OncoGenex Pharma reports that Data from a Phase 2 Study presented continues to show early activity of OGX-427 in patients with Prostate Cancer; The authors concluded that OGX-427 appears to be well-tolerated Briefing.com |
| 08:01AM | OncoGenex announces data from Phaes 2 study of OGX-427 theflyonthewall.com |
| 08:01AM | Data from a Phase 2 Study Presented at the 2012 ASCO Annual Meeting Continues to Show Early Activity of OGX-427 in Patients with Prostate Cancer CNW Group |
